BDI Pharma, Inc. announced the launch of its Drug Supply Chain Security Act (DSCSA) compliant solution with partner TraceLink.
This new service provides customers a one-stop solution for accessing all T3 compliance data from BDI Pharma (transaction information, transaction history and transaction statements) in one central repository that will be retained for a minimum of six years, as is required by the DSCSA.
“Providing a user-friendly electronic solution for accessing and retaining transaction data assists our partners with achieving their compliance requirements,” stated Rich Gaton, co-founder and president of BDI Pharma, Inc. “In maintaining our focus on improving the quality and safety of the supply chain, we also wanted to invest in a solution that prepares us to integrate electronically with our trading partners to meet their upcoming DSCSA requirements, as well.”
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
